MMP14 and glioblastoma: Utilizing bioinformatics analysis of the REMBRANDT dataset, we confirmed a significant correlation between increased MT1-MMP expression with advanced tumor grades, malignancy and shorter overall survival for GBM patients, in concordance with previously reported results[15,17,49].